An extended pi-system and enhanced electronic delocalization on symmetric [Ru3O(CH3COO)(6)(L)(3)](n) complexes combined with azanaphthalene ligands

Author(s)

Possato, Bruna ; Deflon, Victor M. ; Naal, Zeki ; Formiga, Andre L. B. ; Nikolaou, Sofia

• Document type: Journal article
• Source: DALTON TRANSACTIONS; v. 46, n. 24, p. 7926-7938, JUN 28 2017.
• Web of Science Citations: 4

Abstract

We report on the investigation of a new series of symmetric trinuclear ruthenium complexes combined with azanaphthalene ligands: {[}Ru3O(CH3COO)(6)(L)(3)]PF6 where L = (1) quinazoline (qui), (2) 5-nitroisoquinoline (5-nitroiq), (3) 5-bromoisoquinoline (5-briq), (4) isoquinoline (iq), (5) 5-aminoisoquinoline (5-amiq), and (6) 5,6,7,8-tetrahydroisoquinoline (thiq). The crystal structure of complex 1, {[}Ru3O (CH3COO)(6)(qui)(3)]PF6, was determined by X-ray diffraction analysis, showing a high degree of co-planarity between the {[}Ru3O] plane and the azanaphthalene ligands. Spectroscopic (UV-visible, NMR and infra-red) and electrochemical (cyclic voltammetry and spectroelectrochemistry) data showed correlation with the pKa values of the azanaphthalene ligands and this dependence was rationalized in terms of the molecular orbital of the {[}Ru3O] unit and the structure of the ligands. By analysing the spectroscopic and electrochemical correlations, the ability of the azanaphthalene ligands to extend the electronic p-system of the {[}Ru3O] unit to the periphery of the compounds was demonstrated. This electronic effect accounts for the planarity of the structure of complex 1. It was also shown through molecular modeling results that, to explain the spectroscopic and electrochemical behaviour of these species, it is not possible to neglect the electronic mixing between the metallic and the acetate orbitals. Finally, this work revealed that electronic coupling is more pronounced in the azanaphthalene series of complexes than in pyridinic analogues and it is this coupling that determines the spectroscopic and electrochemical behaviour of the new species. (AU)

• FAPESP's process: 15/20302-7 - Using non-steroidal antiinflammatory drugs, azanaphtalenes and phenazines as ligands for the development of bi- and trinuclear rutenium carboxylates with potential antialergic, tumoricide and tripanocide activities
• Grantee: Sofia Nikolaou
• Support type: Regular Research Grants
• FAPESP's process: 13/22127-2 - Development of novel materials strategic for integrated analytical devices
• Grantee: Lauro Tatsuo Kubota
• Support type: Research Projects - Thematic Grants